GlaxoSmithKline settles for $105 million
GlaxoSmithKline settles for $105 million over label dispute with 45 states. GlaxoSmithKline has agreed to pay $105 million to 45
Read MoreFaulty Pharmaceutical Drugs Resources
GlaxoSmithKline settles for $105 million over label dispute with 45 states. GlaxoSmithKline has agreed to pay $105 million to 45
Read More